Methotrexate in juvenile idiopathic arthritis: advice and recommendations from the MARAJIA expert consensus meeting

Methotrexate in juvenile idiopathic arthritis: advice and recommendations from the MARAJIA expert consensus meeting

Abstract Background Conventional pharmacological therapies for the treatment of juvenile idiopathic arthritis (JIA) consist of non-biological, disease-modifying antirheumatic drugs, among which methotrexate (MTX) is the most commonly prescribed. However, there is a lack of consensus-based clinical a...

Full description

Bibliographic Details
Main Authors: Giovanna Ferrara, Greta Mastrangelo, Patrizia Barone, Francesco La Torre, Silvana Martino, Giovanni Pappagallo, Angelo Ravelli, Andrea Taddio, Francesco Zulian, Rolando Cimaz, On behalf of the Rheumatology Italian Study Group
Format: Article
Language:English
Published: BMC 2018-07-01
Series:Pediatric Rheumatology Online Journal
Subjects:
Juvenile idiopathic arthritis
Methotrexate
Consensus
Online Access:http://link.springer.com/article/10.1186/s12969-018-0255-8

Internet

http://link.springer.com/article/10.1186/s12969-018-0255-8

Similar Items